✦ LIBER ✦

S-16-4 Xanomeline: The first study of the safety and efficacy of an M1 agonist in mild and moderate Alzheimer's disease

✍ Scribed by Neil C. Bodick; Walter Offen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Xanomeline, a potent and specific M1 ago

✍ Pretzsch, Hans 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 123 KB

SAT-5-3 Xanomeline in mild and moderate

✍ Neil C. Bodick; Walter Offen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 278 KB

The safety and tolerance of Xanomeline t

✍ Cutler, NR; Sramek, JJ; Seifert, RD; Conrad, JJ; Wardle, TS; Dies, F; Hurley, DJ 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Efficacy and safety of the alpha7 agonis

✍ Gault, Laura; Ritchie, Craig; Robieson, Weining; Pritchett, Yili; Othman, Ahmed; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

41-5 - Transdermal delivery of xanomelin

✍ N.C. Bodick; R. Lucas; J.H. Satterwhite; W.W. Offen 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Evaluation of the efficacy and safety of

✍ Marek, Gerard; Katz, David; Meier, Andreas; Greco, Nicholas; Zhang, Wuyan; Liu, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB